Study of INCB123667 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
- Status
- WITHDRAWN
- Phase
- PHASE3
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
- Status
- WITHDRAWN
- Phase
- PHASE2
Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement
- Status
- COMPLETED
- Phase
- PHASE2
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB086550
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE1
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
- Status
- RECRUITING
- Phase
- PHASE2
Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia
- Status
- TERMINATED
- Phase
- PHASE3
Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib Cream in Children With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Study of INCA 0186 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
- Status
- COMPLETED
- Phase
- N/A
The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2